Symptoms of Siderosis in the Lungs

Unlike most other chronic lung diseases, siderosis does not produce obvious symptoms. In fact, people may not realize they have siderosis unless a chest X-ray reveals small nodules in the lower half of the lungs, which are the only discernable signs of this condition. Despite having little to no symptoms, however, some researchers believe lung function may be slightly compromised due to the prolonged inhalation of iron oxide fumes or dust.

While siderosis alone does not lead to noticeable symptoms, it can increase the risk of other lung conditions like emphysema and chronic obstructive pulmonary disease (COPD) that make it difficult to engage in physical activity or even perform daily actions like walking. These diseases may cause shortness of breath, persistent coughing and a reduction in overall quality of life. Traditional treatments for chronic lung disease include supplemental oxygen, medications and breathing exercises, but not everyone is able to find satisfactory symptom relief from these approaches.

The Lung Institute offers a new source of hope to patients with chronic lung diseases related to siderosis. The first stem cell center in the nation to focus exclusively on lung conditions, the Lung Institute is a leader in autologous stem cell therapy, a minimally invasive breakthrough treatment that leverages the patient’s own stem cells to stimulate the body’s natural healing processes. While there is not yet a cure for emphysema, COPD and related lung diseases, stem cell therapy has the potential to reduce lung inflammation and lessen the severity of symptoms in certain patients.

If you are experiencing symptoms from siderosis-related conditions, allow the Lung Institute to help you breathe easier. A member of our compassionate team will be happy to inform you about our innovative treatment and determine if stem cell therapy may be right for you. To take the first step toward finding relief from your symptoms, call (800) 729-3065 today.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.